Gene therapy makes heart failure recovery more affordable than ever

Author：  

Publisher： Adis International

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.614, 2010-01, pp. : 1-1

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Carvedilol Exerts More Potent Antiadrenergic Effect than Metoprolol in Heart Failure

By Kohno Takashi   Yoshikawa Tsutomu   Yoshizawa Akihiro   Nakamura Iwao   Anzai Toshihisa   Satoh Toru   Ogawa Satoshi  

Cardiovascular Drugs and Therapy, Vol. 19, Iss. 5, 2005-10 ,pp. : 347-355

Springer Publishing Company

Access to resources Recommend Favorite

Metabolic Therapy of Heart Failure

By  

Current Pharmaceutical Design, Vol. 14, Iss. 25, 2008-09 ,pp. : 2582-2591

Bentham Science Publishers

Access to resources Recommend Favorite

Gene therapy and heart transplantation

By Ardehali A.   Reddy R.   Laks H.  

Expert Opinion on Investigational Drugs, Vol. 9, Iss. 5, 2000-05 ,pp. : 1021-1027

Informa Healthcare

Access to resources Recommend Favorite

Pharmacologic Therapy of Chronic Heart Failure

By Hamad Eman   Mather Paul J.   Srinivasan Siva   Rubin Sharon   Whellan David J.   Feldman Arthur M.  

American Journal of Cardiovascular Drugs, Vol. 7, Iss. 4, 2007-01 ,pp. : 235-248

Adis International

Access to resources Recommend Favorite

-Blocker therapy in heart failure reviewed

By  

Inpharma, Vol. 1, Iss. 1327, 2002-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite